ETC 216 [aapp, lipd]
Atherosclerosis [dsyn]
therapy [ftcn]
treatment [ftcn]
Acute Coronary Syndrome [dsyn]
Atherosclerotic Cardiovascular Disease [dsyn]
Leading [tmco]
U S [geoa]
Cholesterol, LDL [bacs, strd]
lowering [spco]
Drug Therapy [topp]
Standard [qlco]
treatment [ftcn]
low hdl [fndg]
Levels [qlco]
Increased [qnco]
coronary heart disease [dsyn]
Attractive [qlco]
strategy [menp]
treatment [ftcn]
Atherosclerosis [dsyn]
Levels [qlco]
reverse cholesterol transport [celf]
Apolipoprotein A-I [aapp, bacs]
Structural protein [aapp, bacs]
Play [dora]
reverse cholesterol transport [celf]
Make [ftcn]
Enhance [acty]
Target [ftcn]
Attractive [qlco]
Target [ftcn]
apolipoprotein A-I Milano [aapp]
Molecular [qlco]
Variant [qlco]
Human [humn]
Apolipoprotein A-I [aapp, bacs]
Wild Type [orga]
Apolipoprotein A-I [aapp, bacs]
Cys [aapp, bacs]
Substitution [idcn]
Leading [tmco]
formation [biof]
disulfide [chvs]
Link [inpr]
Apo A-I Milano [aapp]
Improved [qlco]
Capacity [qnco]
Cell [cell]
Cholesterol [bacs, strd]
Removal [topp]
Recently [tmco]
recombinant [orgm]
Form [qlco]
Apo A-I Milano [aapp]
Escherichia coli [bact]
Complex [qlco]
Phospholipid [bacs, lipd]
1-palmitoyl-2-oleoyl-phosphatidylcholine [bacs, lipd]
Native [ftcn]
synthetic [acty]
referred [ftcn]
ETC 216 [aapp, lipd]
arrested [dsyn]
smooth muscle cell proliferation [celf]
PREVENT [phsu]
Neointima Formation [patf]
Rabbit [mamm]
Vascular injury [inpo]
arrested [dsyn]
In [qnco]
Stent [medd]
Stenosis [patf]
porcine [mamm]
Coronary Arteries [bpoc]
ETC 216 [aapp, lipd]
Efficacy [qlco]
Clinical Trials [resa]
Regression [patf]
Coronary Atherosclerosis [dsyn]
Patients [podg]
Syndromes, Acute Coronary [dsyn]
ETC 216 [aapp, lipd]
Continue [idcn]
Phase [tmco]
Ii [aapp]
treatment [ftcn]
Prevention [topp]
Atherosclerosis [dsyn]
Syndromes, Acute Coronary [dsyn]
